MEDX ... anybody following? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following?

MEDX 31.14

-0.1%

10:04 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: tnsaf	8/22/2009 1:28:16 AM
	of 2240

Maybe it isn't a done deal, although I can't see the people buying since the offer not tendering. NEW YORK (AP) — Bristol-Myers Squibb Co. said Thursday it's extending its cash tender offer to buy up shares of biotech company Medarex Inc. until Aug. 26. The tender offer originally was set to expire on Aug. 24. All other terms of the deal remain the same. Bristol-Myers said in July it would pay $16 per share, or $2.1 billion, to acquire Princeton, N.J.-based Medarex. As of Thursday, less than 9 percent of Medarex's outstanding shares had been tendered. The acquisition would give Bristol-Myers, the maker of blood thinner Plavix, access to drug candidates aimed at immunologic disorders. The Medarex board has recommended that stockholders tender their shares.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next